Pyxis Oncology Inc.

NASDAQ: PYXS · Real-Time Price · USD
1.21
0.08 (7.08%)
At close: Aug 15, 2025, 3:59 PM
1.21
0.00%
After-hours: Aug 15, 2025, 07:37 PM EDT

Pyxis Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-77.33M -73.79M -120.72M -75.97M
Depreciation & Amortization
2.98M 1.93M 709K 647K
Stock-Based Compensation
12.95M 16.95M 15.76M 6.44M
Other Working Capital
-13.02M -8.16M 12.83M 2.03M
Other Non-Cash Items
15.55M -4.13M 10.41M 20.6M
Deferred Income Tax
n/a n/a n/a 6.28M
Change in Working Capital
-11.82M -11.66M 4.5M 6.68M
Operating Cash Flow
-57.67M -70.71M -89.33M -35.33M
Capital Expenditures
-237K -6.73M -6.4M -540K
Cash Acquisitions
n/a 6.66M n/a -50K
Purchase of Investments
-160.12M -196.83M n/a -50K
Sales Maturities Of Investments
168.51M 92.05M n/a 50.05K
Other Investing Acitivies
n/a n/a n/a -50
Investing Cash Flow
8.15M -104.85M -6.4M -590K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-240K -193K 183K 167K
Financial Cash Flow
59.33M 5.93M 183K 304.04M
Net Cash Flow
9.81M -169.63M -95.55M 268.13M
Free Cash Flow
-57.91M -77.44M -95.73M -35.87M